$AGIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AGIOS PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AGIOS PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 08 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 80.87 | 600 | 48,522 | 57,196 | 57.8 K to 57.2 K (-1.04 %) |
| Aug 08 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 80.15 | 2,100 | 168,315 | 57,796 | 59.9 K to 57.8 K (-3.51 %) |
| Aug 08 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 78.32 | 300 | 23,496 | 59,896 | 60.2 K to 59.9 K (-0.50 %) |
| Aug 08 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 3,000 | 27,150 | 60,196 | 57.2 K to 60.2 K (+5.25 %) |
| Jul 27 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 62,700 | |
| Jul 27 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 84.58 | 2,050 | 173,389 | 0 | 2.1 K to 0 (-100.00 %) |
| Jul 27 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| Jul 24 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Jul 24 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Jul 24 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 0.00 | 6,265 | 0 | 6,265 | |
| Jul 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 2,000 | 70,320 | 93,000 | |
| Jul 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 87.26 | 800 | 69,808 | 924 | 1.7 K to 924 (-46.40 %) |
| Jul 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 86.42 | 1,200 | 103,704 | 1,724 | 2.9 K to 1.7 K (-41.04 %) |
| Jul 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 2,000 | 70,320 | 2,924 | 924 to 2.9 K (+216.45 %) |
| Jul 11 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 52.29 | 272 | 14,223 | 12,578 | |
| Jul 11 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 84.94 | 272 | 23,104 | 0 | 272 to 0 (-100.00 %) |
| Jul 11 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 52.29 | 272 | 14,223 | 272 | 0 to 272 |
| Jul 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 3,000 | 27,150 | 16,154 | |
| Jul 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 84.32 | 300 | 25,296 | 57,196 | 57.5 K to 57.2 K (-0.52 %) |
| Jul 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 83.41 | 2,700 | 225,207 | 57,496 | 60.2 K to 57.5 K (-4.49 %) |
| Jul 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 3,000 | 27,150 | 60,196 | 57.2 K to 60.2 K (+5.25 %) |
| Jun 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 64,750 | |
| Jun 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 97.58 | 2,050 | 200,039 | 0 | 2.1 K to 0 (-100.00 %) |
| Jun 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| Jun 18 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | M | 50.73 | 9,000 | 456,570 | 0 | |
| Jun 18 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Sell | S | 94.30 | 839 | 79,118 | 2,200 | 3 K to 2.2 K (-27.61 %) |
| Jun 18 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Sell | S | 93.78 | 5,980 | 560,804 | 3,039 | 9 K to 3 K (-66.30 %) |
| Jun 18 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Sell | S | 92.62 | 2,181 | 202,004 | 9,019 | 11.2 K to 9 K (-19.47 %) |
| Jun 18 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Buy | M | 50.73 | 9,000 | 456,570 | 11,200 | 2.2 K to 11.2 K (+409.09 %) |
| Jun 14 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 2,000 | 70,320 | 95,000 | |
| Jun 14 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 93.37 | 200 | 18,674 | 881 | 1.1 K to 881 (-18.50 %) |
| Jun 14 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 92.84 | 1,800 | 167,112 | 1,081 | 2.9 K to 1.1 K (-62.48 %) |
| Jun 14 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 2,000 | 70,320 | 2,881 | 881 to 2.9 K (+227.01 %) |
| Jun 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 3,000 | 27,150 | 19,154 | |
| Jun 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 94.28 | 939 | 88,529 | 57,196 | 58.1 K to 57.2 K (-1.62 %) |
| Jun 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 93.27 | 1,259 | 117,427 | 58,135 | 59.4 K to 58.1 K (-2.12 %) |
| Jun 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 92.45 | 802 | 74,145 | 59,394 | 60.2 K to 59.4 K (-1.33 %) |
| Jun 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 3,000 | 27,150 | 60,196 | 57.2 K to 60.2 K (+5.25 %) |
| Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 2.34 | 108 | 253 | 72,619 | |
| Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.47 | 12,892 | 6,027 | 0 | |
| Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 96.91 | 100 | 9,691 | 0 | 100 to 0 (-100.00 %) |
| Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 96.40 | 3,190 | 307,516 | 100 | 3.3 K to 100 (-96.96 %) |
| Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 95.11 | 8,200 | 779,902 | 3,290 | 11.5 K to 3.3 K (-71.37 %) |
| Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 94.37 | 1,510 | 142,499 | 11,490 | 13 K to 11.5 K (-11.62 %) |
| Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 2.34 | 108 | 253 | 13,000 | 12.9 K to 13 K (+0.84 %) |
| Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.47 | 12,892 | 6,027 | 12,892 | 0 to 12.9 K |
| Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 0.00 | 1,400 | 0 | 1,400 | |
| Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 93.50 | 5,700 | 532,950 | 5,700 | |
| Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 0.00 | 1,400 | 0 | 1,400 | |
| Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 93.50 | 5,700 | 532,950 | 5,700 | |
| Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | A | 0.00 | 1,400 | 0 | 1,400 | |
| Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | A | 93.50 | 5,700 | 532,950 | 5,700 | |
| Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Option Exercise | A | 0.00 | 1,400 | 0 | 1,400 | |
| Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Option Exercise | A | 93.50 | 5,700 | 532,950 | 5,700 | |
| Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | A | 0.00 | 1,400 | 0 | 1,400 | |
| Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | A | 93.50 | 5,700 | 532,950 | 5,700 | |
| Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.47 | 23,471 | 10,973 | 12,892 | |
| Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 16,193 | 4,898 | 0 | |
| Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 5,962 | 1,804 | 0 | |
| Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 90.07 | 45,626 | 4,109,534 | 0 | 45.6 K to 0 (-100.00 %) |
| Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.47 | 23,471 | 10,973 | 45,626 | 22.2 K to 45.6 K (+105.94 %) |
| Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 16,193 | 4,898 | 22,155 | 6 K to 22.2 K (+271.60 %) |
| Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 5,962 | 1,804 | 5,962 | 0 to 6 K |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 49,374 | 14,936 | 16,193 | |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 92.03 | 299 | 27,517 | 0 | 299 to 0 (-100.00 %) |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 91.60 | 9,301 | 851,972 | 299 | 9.6 K to 299 (-96.89 %) |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 90.11 | 39,774 | 3,584,035 | 9,600 | 49.4 K to 9.6 K (-80.56 %) |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 49,374 | 14,936 | 49,374 | 0 to 49.4 K |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 66,800 | |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 85.76 | 2,050 | 175,808 | 0 | 2.1 K to 0 (-100.00 %) |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 31.64 | 15,177 | 480,200 | 14,862 | |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 90.00 | 15,177 | 1,365,930 | 57,196 | 72.4 K to 57.2 K (-20.97 %) |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 31.64 | 15,177 | 480,200 | 72,373 | 57.2 K to 72.4 K (+26.54 %) |
| May 10 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 2,000 | 70,320 | 99,000 | |
| May 10 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 81.38 | 2,000 | 162,760 | 881 | 2.9 K to 881 (-69.42 %) |
| May 10 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 2,000 | 70,320 | 2,881 | 881 to 2.9 K (+227.01 %) |
| May 08 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 3,000 | 27,150 | 22,154 | |
| May 08 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 81.81 | 3,000 | 245,430 | 57,196 | 60.2 K to 57.2 K (-4.98 %) |
| May 08 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 3,000 | 27,150 | 60,196 | 57.2 K to 60.2 K (+5.25 %) |
| May 03 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 13,000 | 3,933 | 65,567 | |
| May 03 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 84.35 | 100 | 8,435 | 0 | 100 to 0 (-100.00 %) |
| May 03 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 83.56 | 2,814 | 235,138 | 100 | 2.9 K to 100 (-96.57 %) |
| May 03 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 82.88 | 10,086 | 835,928 | 2,914 | 13 K to 2.9 K (-77.58 %) |
| May 03 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 13,000 | 3,933 | 13,000 | 0 to 13 K |
| Apr 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 68,850 | |
| Apr 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 85.95 | 2,050 | 176,198 | 0 | 2.1 K to 0 (-100.00 %) |
| Apr 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| Apr 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 2,000 | 70,320 | 101,000 | |
| Apr 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 85.68 | 700 | 59,976 | 881 | 1.6 K to 881 (-44.28 %) |
| Apr 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 84.78 | 1,300 | 110,214 | 1,581 | 2.9 K to 1.6 K (-45.12 %) |
| Apr 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 2,000 | 70,320 | 2,881 | 881 to 2.9 K (+227.01 %) |
| Apr 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 3,000 | 27,150 | 25,154 | |
| Apr 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 77.17 | 500 | 38,585 | 57,196 | 57.7 K to 57.2 K (-0.87 %) |
| Apr 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 76.17 | 800 | 60,936 | 57,696 | 58.5 K to 57.7 K (-1.37 %) |
| Apr 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 75.04 | 400 | 30,016 | 58,496 | 58.9 K to 58.5 K (-0.68 %) |
| Apr 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 73.90 | 1,300 | 96,070 | 58,896 | 60.2 K to 58.9 K (-2.16 %) |
| Apr 09 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 3,000 | 27,150 | 60,196 | 57.2 K to 60.2 K (+5.25 %) |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 13,000 | 3,933 | 78,567 | |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 79.49 | 2,113 | 167,962 | 0 | 2.1 K to 0 (-100.00 %) |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 78.59 | 3,390 | 266,420 | 2,113 | 5.5 K to 2.1 K (-61.60 %) |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 77.76 | 3,340 | 259,718 | 5,503 | 8.8 K to 5.5 K (-37.77 %) |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 76.40 | 2,600 | 198,640 | 8,843 | 11.4 K to 8.8 K (-22.72 %) |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 75.54 | 1,557 | 117,616 | 11,443 | 13 K to 11.4 K (-11.98 %) |
| Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 13,000 | 3,933 | 13,000 | 0 to 13 K |
| Mar 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 2.34 | 4,100 | 9,594 | 27,718 | |
| Mar 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 37 | 17 | 1,766 | |
| Mar 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 2.34 | 4,100 | 9,594 | 57,196 | 53.1 K to 57.2 K (+7.72 %) |
| Mar 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 37 | 17 | 53,096 | 53.1 K to 53.1 K (+0.07 %) |
| Mar 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 70,900 | |
| Mar 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 84.65 | 2,050 | 173,533 | 0 | 2.1 K to 0 (-100.00 %) |
| Mar 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| Mar 21 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | M | 47.33 | 6,800 | 321,844 | 0 | |
| Mar 21 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Sell | S | 81.97 | 6,800 | 557,396 | 2,200 | 9 K to 2.2 K (-75.56 %) |
| Mar 21 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Buy | M | 47.33 | 6,800 | 321,844 | 9,000 | 2.2 K to 9 K (+309.09 %) |
| Mar 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Buy | P | 83.44 | 200 | 16,688 | 571 | 371 to 571 (+53.91 %) |
| Mar 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Buy | P | 83.44 | 200 | 16,688 | 571 | 371 to 571 (+53.91 %) |
| Mar 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 2,000 | 70,320 | 103,000 | |
| Mar 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 82.90 | 300 | 24,870 | 881 | 1.2 K to 881 (-25.40 %) |
| Mar 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 82.23 | 1,700 | 139,791 | 1,181 | 2.9 K to 1.2 K (-59.01 %) |
| Mar 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 2,000 | 70,320 | 2,881 | 881 to 2.9 K (+227.01 %) |
| Mar 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 3,000 | 27,150 | 28,154 | |
| Mar 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 84.10 | 1,100 | 92,510 | 53,059 | 54.2 K to 53.1 K (-2.03 %) |
| Mar 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 83.21 | 1,100 | 91,531 | 54,159 | 55.3 K to 54.2 K (-1.99 %) |
| Mar 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 82.04 | 400 | 32,816 | 55,259 | 55.7 K to 55.3 K (-0.72 %) |
| Mar 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 80.93 | 400 | 32,372 | 55,659 | 56.1 K to 55.7 K (-0.71 %) |
| Mar 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 3,000 | 27,150 | 56,059 | 53.1 K to 56.1 K (+5.65 %) |
| Feb 28 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | M | 47.33 | 2,200 | 104,126 | 6,800 | |
| Feb 28 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Buy | M | 47.33 | 2,200 | 104,126 | 2,200 | 0 to 2.2 K |
| Feb 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 72,950 | |
| Feb 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 78.63 | 2,050 | 161,192 | 0 | 2.1 K to 0 (-100.00 %) |
| Feb 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 0.00 | 2,370 | 0 | 2,370 | |
| Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 0.00 | 2,800 | 0 | 2,800 | |
| Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 77.70 | 9,480 | 736,596 | 9,480 | |
| Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 0.00 | 8,250 | 0 | 8,250 | |
| Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 77.70 | 33,000 | 2,564,100 | 33,000 | |
| Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 8,250 | 0 | 8,250 | |
| Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 77.70 | 33,000 | 2,564,100 | 33,000 | |
| Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | A | 0.00 | 8,250 | 0 | 8,250 | |
| Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | A | 77.70 | 33,000 | 2,564,100 | 33,000 | |
| Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | A | 0.00 | 24,375 | 0 | 24,375 | |
| Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | A | 77.70 | 97,500 | 7,575,750 | 97,500 | |
| Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 2,936 | 26,571 | 31,154 | |
| Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 64 | 30 | 1,803 | |
| Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 78.03 | 400 | 31,212 | 53,059 | 53.5 K to 53.1 K (-0.75 %) |
| Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 76.76 | 701 | 53,809 | 53,459 | 54.2 K to 53.5 K (-1.29 %) |
| Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 75.70 | 1,100 | 83,270 | 54,160 | 55.3 K to 54.2 K (-1.99 %) |
| Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 74.89 | 799 | 59,837 | 55,260 | 56.1 K to 55.3 K (-1.43 %) |
| Feb 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 2,936 | 26,571 | 56,059 | 53.1 K to 56.1 K (+5.53 %) |